Drug Search Results
More Filters [+]

ATH-274

Alternative Names: ATH-274, ATH274, ATH 274
Latest Update: 2023-07-07
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Athos
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ATH-274

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 0: Acute Myeloid Leukemia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title